Ndonovo Therapeutics Inc (ENDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 30 | 35 | 12 | 40 | 45 |
| Cost of Goods | 1 | -3 | 47 | 1 | 11 |
| Gross Profit | 30 | 32 | -36 | 39 | 33 |
| Operating Expenses | 600 | 620 | 696 | 987 | 647 |
| Operating Income | -570 | -590 | -684 | -947 | -602 |
| Interest Expense | 120 | 347 | 553 | 432 | 264 |
| Other Income | -606 | -1,743 | -794 | 310 | -769 |
| Pre-tax Income | -1,297 | -2,681 | -2,030 | -1,069 | -1,635 |
| Net Income Continuous | -1,297 | -2,681 | -2,030 | -1,069 | -1,635 |
| Net Income | $-1,297 | $-2,681 | $-2,030 | $-1,069 | $-1,635 |
| EPS Basic Total Ops | -0.02 | -0.06 | -1.26 | -0.07 | -0.17 |
| EPS Basic Continuous Ops | -0.02 | -0.06 | -1.27 | -0.07 | -0.17 |
| EPS Diluted Total Ops | -0.02 | -0.06 | 0.35 | -0.07 | -0.17 |
| EPS Diluted Continuous Ops | -0.02 | -0.06 | -0.16 | -0.07 | -0.17 |
| EBITDA(a) | $-378 | $-380 | $-347 | $-770 | $-423 |